Companies have seen rising labour and energy costs start to crimp their margins. Natalie Tam, Investment Director at Aberdeen Standard Investments told us that while these sort of challenges are uncontrollable, some companies are better placed to respond than others, and outlines two stock examples. In this short video Natalie... Show More

Schroders Australia

It has long been difficult to place rationale around valuations in certain areas of the market. While the supermodels get all the spotlights, it’s the cardigan wearing brigade that seem more like a solid investment, allowing scope for many different futures — both good and not so good — without... Show More

Robert Penaloza

With the Socceroos carrying the hopes of a nation into the tournament, the Australian equities team at Aberdeen Standard Investments has selected its own dream team of locally listed stocks. Just like Australia’s coach, Bert van Marwijk, the investment team sought to combine skills and strength in its final XI... Show More

Harley Grosser

Rhinomed Ltd (ASX:RNO) is a nasal, respiratory and breathing management technology firm based in Melbourne with a US office in Cincinatti. The company is developing and commercialising its technology platform in the sports, sleep, cold & allergy and drug delivery markets. The technology is based on an adjustable nasal stent... Show More

Robert Frost

Portfolio stalwart, Fisher and Paykel Healthcare (ASX:FPH), continues to deliver for investors after announcing another typically strong full-year profit result, up 27% on the prior year. We have long been attracted to FPH’s global growth strategy and were not disappointed as both of the company’s major product groups, hospital/respiratory and... Show More

Wilson Asset Management

Today, Fisher & Paykel Healthcare Corp Limited (ASX: FPH) announced a record net profit after tax of NZ$143.4 million for the year ended 31 March 2016, a 27% increase from the prior year. The company said the profit exceeded expectations of NZ$135-NZ$140 million. FPH shares closed up 2.2% for the... Show More